Methods of treating breast cancer with anthracycline therapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9066963
APP PUB NO 20130004482A1
SERIAL NO

13421367

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The application describes methods for screening subjects with breast cancer to determine if the breast cancer will be responsive to a breast cancer therapy including an anthracycline. The application also describes methods for treating subjects with breast cancer by screening them for the likelihood of the effectiveness of treating the cancer with a therapy including anthracycline and administering the therapy in subjects when it is found that anthracycline is likely to be effective.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • BRITISH COLUMBIA CANCER AGENCY BRANCH;THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL;UNIVERSITY OF UTAH;UNIVERSITY OF WASHINGTON

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bernard, Philip S Salt Lake City, US 19 288
Ellis, Matthew J St. Louis, US 68 655
Nielsen, Torsten O North Vancouver, CA 15 129
Perou, Charles M Carrboro, US 32 235

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 30, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00